Get the Stockscreener App
23.11
0.61%
0.14
After Hours:
23.10
-0.010
-0.04%
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Forecast
The Ishares Genomics Immunology And Healthcare Etf (IDNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $14.89, representing a -35.58% decrease from the current price of $23.11. The highest analyst price target is $16.46, and the lowest is $13.32.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IDNA Price Target
Average 14.47
(-37.40% Downside)
Is Ishares Genomics Immunology And Healthcare Etf (IDNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.41 | Neutral |
| STOCH(9,6) | 24.44 | Neutral |
| STOCHRSI(14) | 6.3526 | Buy |
| MACD(12,26) | -0.1744 | Sell |
| ADX(14) | 18.06 | Neutral |
| William %R | -93.73 | Buy |
| CCI(14) | -179.63 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
24.51
Sell
|
24.11
Sell
|
| MA20 |
24.38
Sell
|
24.32
Sell
|
| MA50 |
24.47
Sell
|
24.40
Sell
|
| MA100 |
24.37
Sell
|
24.27
Sell
|
| MA200 |
23.96
Sell
|
23.75
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, IDNA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on IDNA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.41 indicates that IDNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.44 indicates that IDNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.3526 indicates that IDNA is oversold. This suggests that IDNA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.06 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -179.63 indicates that IDNA is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term IDNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ishares Genomics Immunology And Healthcare Etf financial reports and earnings history, Ishares Genomics Immunology And Healthcare Etf (IDNA) stock could reach $7.0873 by 2030, $40.17 by 2040 and $98.22 by 2050. See the projected annual prices until 2050 of the Ishares Genomics Immunology And Healthcare Etf stock below:
- Ishares Genomics Immunology And Healthcare Etf (IDNA) is expected to reach an average price of $33.78 in 2035, with a high prediction of $35.30 and a low estimate of $35.13. This indicates an $46.18% rise from the last recorded price of $23.11.
- Ishares Genomics Immunology And Healthcare Etf (IDNA) stock is projected to chart a bullish course in 2040, with an average price target of $40.19, representing an $73.92% surge from its current level. The forecast ranges from a conservative $40.45 to a sky-high $40.17.
- Our analysts predict Ishares Genomics Immunology And Healthcare Etf (IDNA) to jump 193.75% by 2045, soaring from $68.81 to an average price of $67.89, potentially reaching $70.60. While $68.81 is the low estimate, the potential upside is significant.
- Ishares Genomics Immunology And Healthcare Etf (IDNA) stock is expected to climb by 2050, reaching an average of $99.16, a $329.08% jump from its current level. However, a wide range of estimates exists, with high and low targets of $98.22 and $98.42, respectively, highlighting the market's uncertainty.
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Year by Year Forecast
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Price Forecast for 2024
Our forecast for IDNA stock price in 2024 now indicates an average price target of $19.27 with a high forecast of $25.22 and a low forecast of $13.32. The average prediction reflects an decrease of -16.62% from the last recorded price of $23.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $13.85 | $13.32 | $16.46 | -40.06% |
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Price Forecast for 2025
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) is expected to reach an average price of $14.47 in 2025, with a high prediction of $19.79 and a low estimate of $9.142. This indicates an -37.40% fall from the last recorded price of $23.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $13.62 | $11.45 | $14.34 | -41.07% |
| February, 2025 | $14.88 | $12.15 | $15.39 | -35.62% |
| March, 2025 | $17.10 | $14.49 | $17.23 | -25.99% |
| April, 2025 | $16.94 | $16.46 | $18.30 | -26.69% |
| May, 2025 | $17.87 | $16.62 | $18.06 | -22.68% |
| June, 2025 | $19.04 | $17.67 | $19.79 | -17.63% |
| July, 2025 | $17.42 | $17.32 | $19.44 | -24.60% |
| August, 2025 | $17.23 | $16.28 | $18.18 | -25.46% |
| September, 2025 | $10.08 | $9.142 | $17.94 | -56.40% |
| October, 2025 | $11.64 | $9.7987 | $11.80 | -49.62% |
| November, 2025 | $11.04 | $10.71 | $12.67 | -52.25% |
| December, 2025 | $10.77 | $10.19 | $12.24 | -53.42% |
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Price Forecast for 2026
The predicted value for Ishares Genomics Immunology And Healthcare Etf (IDNA) in 2026 is set at an average of $9.9647. Estimates vary from a peak of $14.36 to a trough of $5.5649, indicating an -56.88% surge from the present price of $23.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.44 | $10.09 | $12.18 | -50.49% |
| February, 2026 | $9.1584 | $8.8884 | $11.63 | -60.37% |
| March, 2026 | $10.12 | $9.1717 | $10.79 | -56.20% |
| April, 2026 | $7.4682 | $7.2582 | $10.44 | -67.68% |
| May, 2026 | $7.7804 | $5.5649 | $7.9515 | -66.33% |
| June, 2026 | $9.1248 | $6.3448 | $9.6348 | -60.52% |
| July, 2026 | $11.72 | $8.7581 | $12.11 | -49.28% |
| August, 2026 | $11.38 | $10.88 | $12.70 | -50.74% |
| September, 2026 | $13.07 | $11.10 | $13.29 | -43.44% |
| October, 2026 | $13.26 | $12.92 | $14.36 | -42.60% |
| November, 2026 | $12.15 | $12.05 | $13.82 | -47.43% |
| December, 2026 | $9.7131 | $9.4031 | $12.99 | -57.97% |
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ishares Genomics Immunology And Healthcare Etf (IDNA) is $3.5549, with a high forecast of $7.097 and a low forecast of $0.0128. This indicates an -84.62% decrease from the last price of $23.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.113 | $2.5231 | $4.153 | -82.20% |
| February, 2027 | $5.1529 | $3.4679 | $5.3129 | -77.70% |
| March, 2027 | $5.4078 | $4.2629 | $6.2454 | -76.60% |
| April, 2027 | $4.4714 | $3.8977 | $5.8978 | -80.65% |
| May, 2027 | $5.2348 | $3.8127 | $5.9527 | -77.35% |
| June, 2027 | $3.6225 | $2.7675 | $5.4426 | -84.32% |
| July, 2027 | $3.6824 | $3.6574 | $4.7325 | -84.07% |
| August, 2027 | $1.5423 | $1.3323 | $3.8174 | -93.33% |
| September, 2027 | $0.9572 | $0.0128 | $2.3152 | -95.86% |
| October, 2027 | $3.9071 | $0.5622 | $3.9071 | -83.09% |
| November, 2027 | $6.0771 | $3.5621 | $6.4671 | -73.70% |
| December, 2027 | $5.6819 | $5.302 | $7.097 | -75.41% |
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Price Forecast for 2028
In 2028, Ishares Genomics Immunology And Healthcare Etf (IDNA) is projected to reach an average price of $4.925, with a high projection of $8.9368 and a low estimate of $0.9132. This indicates an -78.69% fall from the last price of $23.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.6218 | $5.5869 | $7.8418 | -67.02% |
| February, 2028 | $7.9018 | $7.5568 | $8.9368 | -65.81% |
| March, 2028 | $5.9466 | $5.7666 | $8.4767 | -74.27% |
| April, 2028 | $3.0508 | $2.7408 | $7.7967 | -86.80% |
| May, 2028 | $1.896 | $2.916 | $3.1464 | -91.80% |
| June, 2028 | $1.9595 | $1.9996 | $1.9727 | -91.52% |
| July, 2028 | $0.9729 | $1.7029 | $1.3959 | -95.79% |
| August, 2028 | $2.1471 | $1.2457 | $1.6764 | -90.71% |
| September, 2028 | $0.7632 | $0.9132 | $0.8798 | -96.70% |
| October, 2028 | $2.4766 | $2.1566 | $2.2833 | -89.28% |
| November, 2028 | $3.3076 | $1.5234 | $2.1735 | -85.69% |
| December, 2028 | $5.6069 | $3.7667 | $4.1769 | -75.74% |
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Price Forecast for 2029
The 2029 price forecast for Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) is $4.8873 on average, with a high prediction of $9.7654 and a low estimate of $0.00928. This represents an -78.85% decrease from the previous price of $23.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.1037 | $5.217 | $5.2936 | -86.57% |
| February, 2029 | $1.8264 | $2.0672 | $2.3971 | -92.10% |
| March, 2029 | $0.5894 | $0.2227 | $1.1344 | -97.45% |
| April, 2029 | $0.1459 | $0.00928 | $1.496 | -99.37% |
| May, 2029 | $2.4991 | $0.0726 | $3.5091 | -89.19% |
| June, 2029 | $2.5356 | $2.194 | $3.349 | -89.03% |
| July, 2029 | $0.6922 | $0.5122 | $2.9541 | -97.00% |
| August, 2029 | $10.15 | $0.8538 | $9.7432 | -56.07% |
| September, 2029 | $8.45 | $9.47 | $9.7654 | -63.44% |
| October, 2029 | $8.1785 | $8.4669 | $8.4834 | -64.61% |
| November, 2029 | $7.5154 | $7.6048 | $7.7982 | -67.48% |
| December, 2029 | $8.4196 | $7.5971 | $7.9705 | -63.57% |
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Price Forecast for 2030
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) is expected to reach an average price of $9.5641 in 2030, with a high forecast of $16.38 and a low forecast of $2.7443. This signifies an -58.61% decrease from the last price of $23.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.2807 | $7.099 | $7.0873 | -64.17% |
| February, 2030 | $7.89 | $8.4075 | $8.4041 | -65.86% |
| March, 2030 | $9.2984 | $7.5792 | $8.1643 | -59.76% |
| April, 2030 | $11.51 | $9.7359 | $10.08 | -50.19% |
| May, 2030 | $8.8997 | $11.03 | $11.15 | -61.49% |
| June, 2030 | $7.5357 | $7.7765 | $8.1714 | -67.39% |
| July, 2030 | $4.765 | $5.205 | $5.5982 | -79.38% |
| August, 2030 | $5.2318 | $5.4201 | $4.9884 | -77.36% |
| September, 2030 | $2.9286 | $3.1586 | $4.4335 | -87.33% |
| October, 2030 | $2.5171 | $2.7443 | $2.3653 | -89.11% |
| November, 2030 | $3.864 | $3.5888 | $3.564 | -83.28% |
| December, 2030 | $16.79 | $3.3674 | $16.38 | -27.33% |
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):